Receptor subtypes

Receptors rarely come as a single type. Most form families — groups of related proteins that all respond to the same signalling molecule but differ in structure, location, and what they trigger once activated. Receptor subtypes are the individual members of those families: distinct protein variants that share a broad mechanism but diverge enough to produce meaningfully different effects.

The opioid receptor family has three main subtypes — mu, delta, and kappa — all of which bind endogenous opioids and opioid drugs, but each coupled to different brain circuits and producing different experiences. Serotonin acts on at least fourteen named subtypes. Dopamine has five. A substance's pharmacological profile is shaped not just by which receptor family it engages, but by which subtypes it hits, how strongly, and what it does once bound.

How it works · its role

Each subtype is typically encoded by a distinct gene — or, in some cases, a distinct splice variant of the same gene — giving it a slightly different binding pocket and a different set of downstream signals. When a drug binds a receptor, it triggers an intracellular cascade, and the nature of that cascade depends on the subtype.

Dopamine D1 and D2 receptors, for instance, couple to opposite intracellular pathways: D1 activation tends to increase a second-messenger molecule called cAMP; D2 activation inhibits it. A drug selective for D1 therefore has a different functional signature from one selective for D2, even though both act on dopamine receptors.

Subtypes also differ in where they are expressed. The CB1 cannabinoid receptor is concentrated in the brain and is responsible for psychoactive effects; CB2 is predominantly peripheral and immune-related. A compound selective for CB2 would not be intoxicating.

Relevance to substances & effects

Subtype selectivity explains much of what distinguishes substances within the same broad class — and sometimes across classes that seem superficially unrelated.

Classic psychedelics — LSD, psilocin, mescaline — are strongly active at the 5-HT₂A serotonin subtype, producing their characteristic perceptual and cognitive effects. Salvinorin A, from Salvia divinorum, acts instead at the kappa opioid receptor rather than at 5-HT₂A. That single difference accounts for its unusually dissociative and often dysphoric character compared to classical psychedelics, despite both being classified as psychedelics.

Among opioids, the mu subtype drives pain suppression, respiratory depression, and euphoria; kappa activation tends to produce dysphoria and hallucinations rather than reward. Heroin and morphine are mu-selective; buprenorphine acts at mu as a partial agonist while also binding kappa, which shapes its distinct clinical profile.

Benzodiazepines illustrate how subunit composition — effectively subtype variation within the GABA-A receptor complex — predicts whether a drug skews more sedating, more anxiolytic, or more likely to impair memory.

When a substance page on Psychedex names a specific receptor and subtype, it is pointing to this level of precision: not just the family, but the variant — and the effects that variant's activation produces.